The Advocacy Win That Could Change Hereditary Cancer Care Forever

What if one of the biggest advocacy wins for the hereditary cancer community happened quietly… and most people never even heard about it?

In this episode of BRCA & Beyond, Marisa breaks down the groundbreaking ICD-10 recognition recently granted for Lynch syndrome, BRCA1, BRCA2, and Li-Fraumeni syndrome, and why this could become one of the most important systemic changes hereditary cancer patients have seen in years.

This conversation goes far beyond medical coding. It explores how hereditary cancer patients and previvors have spent years navigating healthcare systems that often had no clear category for them, impacting insurance coverage, preventative care, surveillance approvals, physician education, research funding, and long-term patient outcomes.

Marisa explains:

• What ICD-10 codes actually are (in normal language)

• Why hereditary cancer patients have felt medically invisible

• How BRCA, Lynch syndrome, and Li-Fraumeni patients were previously categorized

• Why proper medical recognition changes healthcare infrastructure

• Insurance denials and preventative screening barriers

• The emotional reality of being “high risk but not sick”

• Why advocacy is more than awareness posts

• How this advocacy win could shape the future of hereditary cancer care

If you are navigating BRCA1, BRCA2, Lynch syndrome, hereditary cancer risk, preventative surgeries, cancer survivorship, previvorship, MRIs, colonoscopies, genetic testing, or insurance challenges, this episode is for you.

This is one of the biggest behind-the-scenes hereditary cancer advocacy wins in recent years, and it has the potential to change how hereditary cancer patients are recognized across healthcare systems moving forward.

SHOW NOTES:

The new ICD-10 codes discussed in this episode are expected to take effect in September 2026.

Fight CRC Announcement:

https://fightcolorectalcancer.org/fight-crc-secures-icd-10-code-for-lynch-syndrome-brca-1-brca-2-li-fraumeni/

Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC):

https://www.cgaigc.com/post/fight-crc-and-cga-igc-members-help-advance-icd-10-recognition-for-lynch-syndrome

Follow BRCA & Beyond for more conversations on hereditary cancer, BRCA mutations, Lynch syndrome, survivorship, previvorship, advocacy, genetic testing, and navigating life after life-changing diagnoses.

If this episode resonated with you, please leave a rating and review. This helps us reach more people navigating previvorship, survivorship, and life after a diagnosis.

Medical Disclaimer

This podcast is for informational and inspirational purposes only and is not intended to replace medical advice, diagnosis, or treatment. Always consult your physician or another qualified healthcare professional before making any medical decisions. The views and experiences shared by guests are their own and do not necessarily reflect the views of the host.

Connect with BRCA & Beyond

Instagram:

🧬 @BRCAandBeyond

💛 @MarisStache

Hosted on Acast. See acast.com/privacy for more information.